↓ Skip to main content

Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report

Overview of attention for article published in Journal of Hematology & Oncology, February 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report
Published in
Journal of Hematology & Oncology, February 2017
DOI 10.1186/s13045-017-0433-z
Pubmed ID
Authors

Hong Li, Weijie Ma, Ken Y. Yoneda, Elizabeth H. Moore, Yanhong Zhang, Lee L. Q. Pu, Garrett M. Frampton, Michael Molmen, Philip J. Stephens, Tianhong Li

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 80 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 24%
Student > Bachelor 8 10%
Researcher 7 9%
Student > Postgraduate 7 9%
Student > Ph. D. Student 6 8%
Other 15 19%
Unknown 18 23%
Readers by discipline Count As %
Medicine and Dentistry 35 44%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Biochemistry, Genetics and Molecular Biology 5 6%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 2 3%
Other 6 8%
Unknown 23 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2024.
All research outputs
#8,636,620
of 25,629,945 outputs
Outputs from Journal of Hematology & Oncology
#624
of 1,300 outputs
Outputs of similar age
#129,164
of 324,844 outputs
Outputs of similar age from Journal of Hematology & Oncology
#18
of 41 outputs
Altmetric has tracked 25,629,945 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,300 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,844 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.